Open AccessPathogenetic links of liver damage, obesity and COVID‑19
Author(s) -
И. Г. Бакулин,
Н. В. Бакулина,
С. В. Тихонов,
S. A. Vinchuk,
В. Д. Декканова,
N. A. Prokofiev
Publication year - 2020
Publication title -
medicinskij alfavit
Language(s) - English
Resource type - Journals
eISSN - 2949-2807
pISSN - 2078-5631
DOI - 10.33667/2078-5631-2020-30-5-10
Subject(s) - waist , obesity , medicine , covid-19 , diabetes mellitus , abdominal obesity , ferritin , type 2 diabetes , gastroenterology , endocrinology , disease , infectious disease (medical specialty)
A retrospective analysis of 73 case histories of COVID‑19 patients were made to study the potential relationship between obesity, liver damage and COVID‑19. The average BMI of the study participants was 30.8 ± 5.8 kg/m2, waist circumference 103.5 ± 13.5 cm, 77 % of patients had abdominal obesity, 71 % of patients had cytolytic syndrome. There was not link between the presence of obesity and the level of transaminases. The degree of transaminases increase depended on the severity of COVID‑19 (level of ferritin, CRP, and oxygen saturation of the blood) and wasn't connected with BMI, waist circumference, and the presence of type 2 diabetes.